Dr. Evan Worden leverages breakthrough technologies such as cryo-EM to investigate the epigenetic mechanisms underpinning cancer, with a focus on posttranslational histone modifications. He earned his Ph.D. in molecular and cell biology from University of California, Berkeley, under the mentorship of Dr. Andreas Martin. Dr. Worden’s graduate work explored protein degradation by the 26S proteasome and answered long-standing questions about the mechanisms that link ubiquitin removal and protein degradation. From there, he joined the lab of Dr. Cynthia Wolberger at Johns Hopkins University as a postdoctoral fellow. Using cryo-EM and biochemical approaches, he elucidated novel functions of Dot1L and COMPASS, two histone lysine methyltransferases that play key roles in gene transcription. In 2021, Dr. Worden joined Van Andel Institute’s Department of Structural Biology as an assistant professor.

He has earned numerous prestigious awards for his research, including a Damon Runyon Cancer Research Foundation Postdoctoral Fellowship, the Paul Ehrlich Award for Postdoctoral Research from Johns Hopkins, and the Nicholas Cozzarelli Prize for best Ph.D. thesis from University of California, Berkeley. In 2020, he was a finalist for the Damon Runyon Dale Frey Award.